USGene is a new resource for freedom-to-operate, prior-art, validity and patent infringement searches and thus complements STN's existing range of biosequence databases
SequenceBase and Fiz Karlsruhe announce the launch of the USPTO Genetic Sequence Database, USGene on STN.
USGene covers all available peptide and nucleic acid sequences from the published applications and issued patents of the United States Patent and Trademark Office (USPTO), from 1982 to date.
The database is ideal for competitive analysis of organisations with biosequence patents and current awareness alerts (SDIs) from the very latest USPTO sequence data.
USGene offers three advanced sequence searching methods; NCBI Blast, the FastA-based Getsim, and Getseq for fragment or motif sequence queries.
The database also provides fully searchable organism name, sequence length, publication sequence identity number (Seq ID NO) and feature tables for modifications and other features.
USGene database includes extensive bibliographic and text search options, including publication title, abstract, patent claims, patent assignees at issue, full inventor names, plus the complete set of publication, application and parent case Wipo/PCT numbers and dates.
Single-click full-text links from USGene sequence records to USPTO original documents on the web are available to all searchers using STN Express and STN on the Web.
"USGene provides a unique searchable combination of biological data - sequences, organism names, molecule types, sequence ID numbers and feature tables - with the original USPTO publication text, especially patent claims." commented Martin Goffman, president and CEO, SequenceBase.
"We are delighted to partner with Fiz Karlsruhe to offer STN patent sequence searchers first access to this new database - an entirely new resource for US freedom-to-operate, prior-art, validity and patent infringement searches".
"The unique combination of USGene with prestigious STN patent sequence databases Dgene (Geneseq), PCTgen and Registry, gives life-science intellectual property professionals the ability to make business critical decisions with greater certainty than was possible before," said Sabine Brunger-Weilandt, president and CEO of Fiz Karlsruhe.
"Fiz Karlsruhe recognises that SequenceBase's USGene database is a truly innovative concept, and we join with our customers to welcome its arrival on STN with great enthusiasm".
From August to September 2007 each STN loginID holder will benefit from a special introductory offer for USGene usage.
